Biogen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biogen and other ETFs, options, and stocks.

About BIIB

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis.

CEO

Christopher A. Viehbacher

CEOChristopher A. Viehbacher

Employees

7,570

Employees7,570

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1978

Founded1978

Employees

7,570

Employees7,570

BIIB Key Statistics

Market cap

21.34B

Market cap21.34B

Price-Earnings ratio

13.23

Price-Earnings ratio13.23

Dividend yield

—

Dividend yield—

Average volume

1.96M

Average volume1.96M

High today

$147.85

High today$147.85

Low today

$145.07

Low today$145.07

Open price

$145.42

Open price$145.42

Volume

5.78M

Volume5.78M

52 Week high

$268.30

52 Week high$268.30

52 Week low

$145.07

52 Week low$145.07

BIIB News

TipRanks 5d

Biogen downgraded to Hold from Buy at Stifel

Stifel analyst Paul Matteis downgraded Biogen (BIIB) to Hold from Buy with a $175 price target It’s been a challenging year and while there are other reasons th...

Analyst ratings

58%

of 36 ratings

Buy

58.3%

Hold

41.7%

Sell